What is D E Hokanson?
D E Hokanson stands as a cornerstone in the vascular health market, specializing in the design and manufacturing of high-precision non-invasive assessment tools. With a legacy spanning over four decades, the company provides essential diagnostic instrumentation to vascular specialists, physicians, and clinical researchers. Their product suite is critical for the detection and management of complex conditions such as Peripheral Artery Disease. By maintaining a commitment to domestic manufacturing and offering industry-leading warranty support, the firm has established a reputation for reliability and technical accuracy that remains unmatched in the clinical setting.
How much funding has D E Hokanson raised?
D E Hokanson has raised a total of $314K across 2 funding rounds:
Debt
$150K
Debt
$164K
Debt (2020): $150K with participation from PPP
Debt (2021): $164K led by PPP
Key Investors in D E Hokanson
PPP
Public-Private Partnership
What's next for D E Hokanson?
With the recent capital injection, D E Hokanson is well-positioned to scale its manufacturing capabilities and expand its footprint in the global vascular diagnostics market. The strategic focus will likely shift toward integrating next-generation digital health features into their existing hardware, ensuring that their diagnostic tools remain at the forefront of clinical innovation. By leveraging this late-stage financing, the company aims to optimize its supply chain and enhance its research and development pipeline, ultimately driving better patient outcomes through superior diagnostic precision and technological durability.
See full D E Hokanson company page
